Ngā hua rapu - Ling-Yuan Kong
- E whakaatu ana i te 1 - 20 hua o te 39
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
-
5
A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma Patients mā S. Farzana Hussain, Ling-Yuan Kong, Justin Jordan, Charles A. Conrad, Timothy Madden, Isabella Fokt, Waldemar Priebe, Amy B. Heimberger
I whakaputaina 2007Artigo -
6
-
7
Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma mā John de Groot, Ji Liang, Ling-Yuan Kong, Jun Wei, Yuji Piao, Gregory N. Fuller, Wei Qiao, Amy B. Heimberger
I whakaputaina 2012Artigo -
8
Understanding Clostridium difficile Colonization mā Monique J. T. Crobach, Jon J. Vernon, Vivian G. Loo, Ling Yuan Kong, Séverine Péchiné, Mark H. Wilcox, Ed J. Kuijper
I whakaputaina 2018Revisão -
9
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme mā Jiemiao Hu, Qingnan Zhao, Ling-Yuan Kong, Jian Wang, Jun Yan, Xueqing Xia, Zhiliang Jia, Amy B. Heimberger, Shulin Li
I whakaputaina 2021Artigo -
10
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells mā Geoffrey Bartholomeusz, Moshe Talpaz, Vaibhav Kapuria, Ling Yuan Kong, Shimei Wang, Zeev Estrov, Waldemar Priebe, Ji Yuan Wu, Nicholas J. Donato
I whakaputaina 2007Artigo -
11
Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells mā Ji Yuan Wu, Feng Meng, Henry Y. Lu, Ling Yuan Kong, William G. Bornmann, Zhenghong Peng, Moshe Talpaz, Nicholas J. Donato
I whakaputaina 2008Artigo -
12
-
13
Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy mā Brett Schrand, Alexey Berezhnoy, Randall Brenneman, Anthony Williams, Agata Levay, Ling-Yuan Kong, Ganesh Rao, Shouhao Zhou, Amy B. Heimberger, Eli Gilboa
I whakaputaina 2014Artigo -
14
Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses mā Ling-Yuan Kong, Adam Wu, Tiffany Doucette, Jun Wei, Waldemar Priebe, Gregory N. Fuller, Wei Qiao, Raymond Sawaya, Ganesh Rao, Amy B. Heimberger
I whakaputaina 2010Artigo -
15
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. mā John J. Letterio, Andrew G. Geiser, Ashok B. Kulkarni, H Dang, Ling‐Yuan Kong, Toru Nakabayashi, Crystal L. Mackall, R E Gress, Anita B. Roberts
I whakaputaina 1996Artigo -
16
-
17
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells mā Ling-Yuan Kong, Jun Wei, Amit Sharma, Jason Barr, Mohamed Abou-Ghazal, Izabela Fokt, Jeffrey S. Weinberg, Ganesh Rao, Elizabeth A. Grimm, Waldemar Priebe, Amy B. Heimberger
I whakaputaina 2008Artigo -
18
-
19
Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase mā Ji Yuan Wu, Feng Meng, Ling-Yuan Kong, Zhenghong Peng, Yunming Ying, William G. Bornmann, Bryant G. Darnay, Betty Lamothe, Hanshi Sun, Moshe Talpaz, Nicholas J. Donato
I whakaputaina 2008Artigo -
20
The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas mā Mohamed Abou-Ghazal, David Yang, Wei Qiao, Chantal Reina-Ortiz, Jun Wei, Ling‐Yuan Kong, Gregory N. Fuller, Nobuyoshi Hiraoka, Waldemar Priebe, Raymond Sawaya, Amy B. Heimberger
I whakaputaina 2008Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Immunology
Cancer research
Medicine
Immune system
Glioma
Internal medicine
Genetics
Signal transduction
Biochemistry
Cell biology
Cancer
STAT3
Gene
Chemistry
Immunotherapy
T cell
Tumor microenvironment
Glioblastoma
Immunosuppression
In vitro
Receptor
STAT protein
CD8
Cytokine
Cytotoxic T cell
FOXP3
Inflammation
Antibody
Chemokine